Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
April 2, 2019 Off

Bio-Rad Names Ilan Daskal Executive Vice President and Chief Financial Officer

By BusinessWire

HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products,…

Encore Dermatology Inc. Acquires SERNIVO®, TRIANEX® and PROMISEB®
April 2, 2019 Off

Encore Dermatology Inc. Acquires SERNIVO®, TRIANEX® and PROMISEB®

By BusinessWire

MALVERN, Pa.–(BUSINESS WIRE)–Encore Dermatology Inc. announced today that it has acquired rights for SERNIVO® (betamethasone dipropionate) Spray, 0.05%, as well…

QUE Oncology Launches Phase II Trials in the United States
April 2, 2019 Off

QUE Oncology Launches Phase II Trials in the United States

By BusinessWire

Biotech creating a new therapy for hot flashes in breast cancer patients launches clinical trials across United States ATLANTA–(BUSINESS WIRE)–Clinical…

April 2, 2019 Off

Centogene names new board members

By Dino Mustafić

Centogene has appointed Dr. Flemming Ornskov to the Supervisory Board and he has also been elected Non-Executive Chairman, effective April 1, 2019.

Johnson & Johnson buy Auris Health for $3.4B, plus milestons payments
April 2, 2019 Off

Johnson & Johnson buy Auris Health for $3.4B, plus milestons payments

By Dino Mustafić

Johnson & Johnson has bought Auris Health, Inc. for about $3.4 billion in cash, with additional payments of up to $2.35 billion, in the aggregate, which may be payable upon reaching certain predetermined milestones, JJ said in a statement Monday.

Sterling Pharma buys CiVentiChem in the US
April 2, 2019 Off

Sterling Pharma buys CiVentiChem in the US

By Dino Mustafić

UK-based contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced its acquisition of CiVentiChem’s US facility located in Cary, North Carolina, US.

Novartis’ Cosentyx approved in China for adult psoriasis patients
April 2, 2019 Off

Novartis’ Cosentyx approved in China for adult psoriasis patients

By Dino Mustafić

Novartis got approval from the China Health Authority NMPA for
Cosentyx, its the first-in-class interleukin-17A inhibitor for moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy.

Molecular Partners, Allergan to file abicipar BLA in USA in the first half of 2019
April 2, 2019 Off

Molecular Partners, Allergan to file abicipar BLA in USA in the first half of 2019

By Dino Mustafić

Allergan and Molecular Partners revealed Tuesday the topline safety results from MAPLE, study which enrolled 123 age-related Neovascular Macular Degeneration (nAMD) patients and evaluated the safety of abicipar produced via a modified manufacturing process, which showed lower incidence and type of IOI.

April 2, 2019 Off

CDISC to Develop Data Standards for Crohn’s Disease With Support from the Helmsley Charitable Trust

By BusinessWire

AUSTIN, Texas & NEW YORK–(BUSINESS WIRE)–CDISC will develop the first global, non-proprietary clinical data standards for Crohn’s disease with a…

April 2, 2019 Off

Global Retinoblastoma Treatment Market Study, 2019: Outlook to 2024 – Non-hereditary Retinoblastoma Expected to Maintain Its Dominance – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Retinoblastoma Treatment Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s offering.…

Posts pagination

Previous 1 … 3,307 3,308 3,309 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine